See All Slides - tctmd.com

Slides

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

Individual and Programmatic CTO Development: Lessons Learned the Hard Way

Presenter: James C. Spratt, Simon J. Walsh, Steven P. Marso

October 31, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Presenter: Seung-Jung Park, Leif Thuesen, Davide Capodanno

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Presenter: Tony Das, Koen Deloose, Michael R. Jaff

October 31, 2016

Advertisement

Slides

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

ABSORB China Clinical Outcomes at 2 Years

Individual and Programmatic CTO Development: Lessons Learned the Hard Way

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Trial #3 - The Essentials of ... the LEADERS FREE trial

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

ABSORB II Clinical Outcomes at 3 Years

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content